Navigation Links
Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
Date:8/5/2008

om our pivotal Phase III clinical studies of the Isolagen Therapy," said Declan Daly, President and Chief Executive Officer of Isolagen. "We intend to file our Biologics License Application (BLA) with the FDA in early 2009 and continue to progress our ongoing Acne trial. I want to thank the clinical investigators and congratulate the Isolagen team for their exceptional performance and clinical achievement in this groundbreaking pivotal study confirming our belief in this innovative approach to aesthetic skin therapy."

About the Studies

The goal of the Phase III multicenter, double-blind, randomized, placebo- controlled studies was to demonstrate the efficacy of three treatments of Isolagen Therapy compared with placebo in the treatment of bilateral nasolabial folds, or wrinkles, six months following the last study treatment, using the co-primary endpoints of:

-- Subject Wrinkle Satisfaction Assessment: the person's own assessment of the wrinkles using a 5-point wrinkle satisfaction scale, and an

-- Evaluator Wrinkle Severity Assessment: the evaluator's live assessment of each of the bilateral nasolabial fold wrinkles at rest using a 6-point ordinal wrinkle severity scale with a photoguide as a reference tool.

Isolagen's Phase III studies for wrinkles were conducted under the Food and Drug Administration's (FDA) Special Protocol Assessment (SPA) regulations. The SPA process results in an agreement with the FDA that successful clinical trial results will form the basis of an efficacy claim for a marketing application. Although significant, the SPA does not guarantee approval of a BLA.

Further, Isolagen is currently conducting a Phase II/III clinical program to investigate the Isolagen Therapy for the treatment of moderate to severe acne scars.

Investor Conference Call

Isolagen will be hosting an investor conference call and webcast on Wednesday, August 6, 2008 at 8:00 a.m. Eastern Time to discuss the results of t
'/>"/>

SOURCE Isolagen, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study
2. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
3. CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
4. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
5. Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study
6. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
7. Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials
8. GeoVax Reports Progress on Its AIDS Vaccine Technology
9. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
10. MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting
11. Alimera Reports Results From the Three-Month Interim Readout of the Human PK Medidur(TM) FA Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015  IRIDEX Corporation (NASDAQ: IRIX ) today ... James H. Mackaness is scheduled to present at the ... am PT in Los Angeles . ... accessed on the Event Calendar of the Investors section of ... webcast will be available shortly after the conclusion of the ...
(Date:5/28/2015)... 2015 Research and Markets ... the "United States Medical Adhesives Market Forecast ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , , ... the United States is projected to ... Medical device manufacturers across the US are expanding ...
(Date:5/28/2015)... The Parenteral Drug Association (PDA) proudly ... of the Johnson & Johnson Kilmer Conference on ... Johnson & Johnson (J&J) is reviving the conference ... endoscopes. J&J ran 8 conferences on sterilization, validation ... on advances in sterilization and other topics. ...
Breaking Medicine Technology:United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 2United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 3PDA Announces Support for the Johnson & Johnson Kilmer Conference 2
(Date:5/28/2015)... Park Cities Pet Sitter is offering a 5-week “Training ... Saturday, June 6th at 10:30am. The classes will be ... Dallas, with a maximum of six dogs allowed in the ... no class being held over the 4th of July weekend. ... Intermediate-to-Advanced level class, dogs will solidify their practical behavior skills, ...
(Date:5/28/2015)... May 28, 2015 New Jersey Plastic ... in delivering world-class results. With over 30 years ... a background in art, Dr. Rafizadeh knows what it ... approach to Plastic Surgery involves the principles of proportion, ... a superior level of comfort and personalized care from ...
(Date:5/28/2015)... As the summer approaches, many people will ... important to make safety a top priority, however, and that’s ... , According to the Centers for Disease Control, 10 people ... including boating incidents. Additionally, the National Safety Council says drowning ... to 4. , Amica is sharing the following tips ...
(Date:5/28/2015)... " Trends Investing ” was featured on NewsWatch as part ... small, medium, and large businesses making an impact in their ... conducted the business review and shared with viewers how this ... their money. , The idea, “let your money work for ... knowing how to succeed are two different things. So ...
(Date:5/28/2015)... 28, 2015 More than 300 locations ... raise money to help the Muscular Dystrophy Association save ... and related life-threatening diseases that limit muscle strength and ... program. , From June 1 to June 30, sweetFrog ... the opportunity to help send local children affected by ...
Breaking Medicine News(10 mins):Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 2Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 3Health News:"NJ Top Doc", Dr. Farhad Rafizadeh is Excited to Offer New Services at his Plastic Surgery Practice 2Health News:"NJ Top Doc", Dr. Farhad Rafizadeh is Excited to Offer New Services at his Plastic Surgery Practice 3Health News:Splash! Amica Shares 6 Swimming Safety Tips 2Health News:An Application to Learn Where to Invest Money was Featured on NewsWatch Television 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 3
... 6, 2011Seven of 10 adults think the U.S. health ... rebuilt, according to a Commonwealth Fund survey released today. ... coordinated care and growing costs. The survey also reveals ... use of teams and information systems. The ...
... HealthDay Reporter , TUESDAY, April 5 (HealthDay News) -- ... indicate the severity of Alzheimer,s disease, but it doesn,t serve ... the findings are helpful because they reveal that signs of ... of the study. "What,s promising is that we can ...
... , TUESDAY, April 5 (HealthDay News) -- ... device shows promise, researchers report. The device, surgically ... six-volt electrical jolt to the carotid arteries. This is ... as baroreflex activation therapy. The researchers were scheduled ...
... HealthDay Reporter , TUESDAY, April 5 (HealthDay News) ... soy will increase the risk of a cancer recurrence, but ... "We did not see any evidence that soy intake ... [from breast cancer]," said Dr. Xiao Ou Shu, a professor ...
... treat people with resistant hypertension helped lower blood pressure by ... to take an additional three or four drugs, on top ... to control their difficult-to-treat condition. The ... Phase III study presented today as a late-breaking clinical trial ...
... -- Thanks to the zebrafish, there is new hope for people ... 8,700 deaths each year in the United States. In a ... journal Nature , and featured on the cover, researchers identified ... and may play a role in up to 70 percent of ...
Cached Medicine News:Health News:New survey: 72 percent of Americans think health-care system needs major overhaul 2Health News:New survey: 72 percent of Americans think health-care system needs major overhaul 3Health News:Blood Marker Suggests Severity of Alzheimer's Disease 2Health News:Blood Marker Suggests Severity of Alzheimer's Disease 3Health News:Implantable Device May Lower Tough-to-Treat Hypertension 2Health News:Implantable Device May Lower Tough-to-Treat Hypertension 3Health News:Soy Foods OK After Breast Cancer: Study 2Health News:Device drops blood pressure in patients with difficult-to-treat hypertension 2Health News:Device drops blood pressure in patients with difficult-to-treat hypertension 3Health News:Researchers use zebrafish to identify new gene linked to melanoma 2Health News:Researchers use zebrafish to identify new gene linked to melanoma 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: